A
Allkem Ltd
XBER:3O10
Allkem Ltd
XBER:3O10
Price:
5.98
EUR
-6.85%
Market Closed
Market Cap:
€3.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Allkem Ltd
XBER:3O10
|
AU |
|
C
|
CH Robinson Worldwide Inc
XBER:CH1A
|
US |
|
Intesa Sanpaolo SpA
MIL:ISP
|
IT |
|
CNOOC Ltd
HKEX:80883
|
CN |
|
Relief Therapeutics Holding SA
F:V6M
|
CH |
|
J
|
JEOL Ltd
XBER:JEL
|
JP |
|
C
|
Cintas Corp
F:CIT
|
US |
|
F
|
Fuji Media Holdings Inc
F:FTN
|
JP |
|
Impala Platinum Holdings Ltd
OTC:IMPUY
|
ZA |
|
A
|
Agios Pharmaceuticals Inc
SWB:8AP
|
US |
|
R
|
Reach PLC
XBER:MRR
|
UK |
|
A
|
AGNC Investment Corp
F:4OQ1
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 3O10's stock price target?
Not Available
3O10 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Allkem Ltd?
Projected CAGR
11%
11%
Over the last 6 years, the compound annual growth rate for Revenue has been 103%. The projected CAGR for the next 7 years is 11%.
What is the Operating Income forecast for Allkem Ltd?
Projected CAGR
7%
7%
The compound annual growth rate for Operating Income over the next 7 years is 7%.
What is the Net Income forecast for Allkem Ltd?
Projected CAGR
11%
11%
Over the last 6 years, the compound annual growth rate for Net Income has been 68%. The projected CAGR for the next 7 years is 11%.
